-
EP1501835
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1501835
| EP1501835 - 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.03.2009 Database last updated on 02.11.2024 | Most recent event Tooltip | 13.11.2009 | Change - representative | published on 16.12.2009 [2009/51] | Applicant(s) | For all designated states Ortho-McNeil Pharmaceutical, Inc. U.S. Route No.202 Raritan, NJ 08869-0602 / US | [2005/05] | Inventor(s) | 01 /
LANTER, James, C. 3 Albion Court Flemington, NJ 08822 / US | 02 /
SUI, Zhihua 11 Running Brook Circle Flemington, NJ 08822 / US | 03 /
FIORDELISO, James, J. 401 Justice Lane Morrisville, PA 19067 / US | [2005/05] | Representative(s) | Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2009/51] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
| Former [2005/05] | Mercer, Christopher Paul, et al Carpmaels & Ransford, 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 03723975.3 | 11.04.2003 | [2005/05] | WO2003US11137 | Priority number, date | US20020376095P | 26.04.2002 Original published format: US 376095 P | [2005/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03090672 | Date: | 06.11.2003 | Language: | EN | [2003/45] | Type: | A2 Application without search report | No.: | EP1501835 | Date: | 02.02.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.11.2003 takes the place of the publication of the European patent application. | [2005/05] | Search report(s) | International search report - published on: | EP | 12.02.2004 | Classification | IPC: | C07D491/04, C07D513/04, C07D498/04, C07D513/06, C07D498/06, A61K31/4738, A61P5/00 | [2005/05] | CPC: |
C07D215/227 (EP,US);
A61P1/14 (EP);
A61P13/08 (EP);
A61P15/10 (EP);
A61P15/16 (EP);
A61P17/02 (EP);
A61P17/14 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P5/00 (EP);
A61P5/28 (EP);
A61P7/00 (EP);
C07D513/04 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/05] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | 2-(CHINOLONYL)-KONDENSIERTE HETEROCYCLEN ALS ANDROGEN REZEPTOR-MODULATOREN | [2005/05] | English: | 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS | [2005/05] | French: | HETEROCYCLES A FUSION 2-(QUINOLONYLE) EN TANT QUE MODULATEURS DU RECEPTEUR D'ANDROGENES | [2005/05] | Entry into regional phase | 25.11.2004 | National basic fee paid | 25.11.2004 | Designation fee(s) paid | 25.11.2004 | Examination fee paid | Examination procedure | 24.11.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 25.11.2004 | Amendment by applicant (claims and/or description) | 25.11.2004 | Examination requested [2005/05] | 15.04.2008 | Despatch of a communication from the examining division (Time limit: M06) | 28.10.2008 | Application deemed to be withdrawn, date of legal effect [2009/17] | 02.12.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/17] | Fees paid | Renewal fee | 25.11.2004 | Renewal fee patent year 03 | 17.03.2006 | Renewal fee patent year 04 | 12.04.2007 | Renewal fee patent year 05 | 28.03.2008 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]WO0116139 (LIGAND PHARM INC [US], et al) [DA] 1-19 * claim - *; | [DA]WO9749709 (LIGAND PHARM INC [US], et al) [DA] 1-19 * claim - *; | [DA]US5696130 (JONES TODD K [US], et al) [DA] 1-19 * claim - *; | [PX]WO02068427 (LIGAND PHARM INC [US], et al) [PX] 1-6,11-19 * example -; claim - *; | [PA]WO02066475 (LIGAND PHARM INC [US], et al) [PA] 1-19 * claim - * |